Extemporaneous Formulations in Pediatric Patients
Download in electronic PDF format for $75
Abstract: Extemporaneous drug formulations are important in treating pediatric patients, and pharmacists have a unique role in compounding these medicines for use in their patients. The author discusses the need for compounding, required studies for extemporaneous formulations (physicochemical properties, physical and chemical stability, palatability and miscellaneous) and new regulations. A table provides a listing of examples of drugs not available in liquids. The author concludes that joint efforts by various groups are required for making extemporaneous formulations accessible to the most vulnerable populations.
Related Keywords:
"off-label" use, chemical stability, children, infants, IV drugs, liquid-dosage form, palatability, pediatric patients, physical stability
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
|
Jul/Aug 1999
Pg. 274-276
|
Pediatric Compounding: Coloring Outside the Lines
Preckshot John
|
Jan/Feb 2001
Pg. 6-8
|
Compounding for the Pediatric Patient
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 84-86
|
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
|
Jan/Feb 2001
Pg. 9-12
|
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
|
Jul/Aug 2019
Pg. 324-331
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007
Pg. 220-225
|
Pediatric Dermatitis
Remmert Renee
|
Nov/Dec 2002
Pg. 419-421
|
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid
Gupta Vishnu D, Ling Jie
|
May/Jun 2001
Pg. 232-233
|
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
|
Jul/Aug 2008
Pg. 372-374
|
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
|
Jan/Feb 2009
Pg. 14-18
|
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
|
Nov/Dec 2005
Pg. 456-461
|
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Gupta Vishnu D
|
May/Jun 2007
Pg. 259-261
|
Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William, Angelle Patricea, Yoch Douglas
|
Jan/Feb 2009
Pg. 6-12
|
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form
Gupta Vishnu D, Gupta Vikas S
|
Jan/Feb 2011
Pg. 78-80
|
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms
Gupta Vishnu D
|
Sep/Oct 2009
Pg. 445-446
|
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Gupta Vishnu D
|
Nov/Dec 2005
Pg. 484-486
|
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form
Gupta Vishnu D, Sood Arun
|
Mar/Apr 2005
Pg. 165-166
|
Pediatric Oral Liquid Preparations
Fonseca Simonne C, Ferreira Anderson de O
|
Nov/Dec 2005
Pg. 437-442
|
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Khokhlova Kateryna O, Zdoryk Oleksandr A
|
May/Jun 2018
Pg. 240-246
|
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S, Thyangarajapuram N
|
Sep/Oct 2003
Pg. 389-393
|
| Return to Top |
